A detailed history of Teza Capital Management LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 10,160 shares of AMLX stock, worth $50,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,160
Previous 13,431 24.35%
Holding current value
$50,393
Previous $38,000 50.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.71 $5,299 - $8,864
-3,271 Reduced 24.35%
10,160 $19,000
Q1 2024

May 15, 2024

SELL
$2.71 - $19.57 $3,330 - $24,051
-1,229 Reduced 8.38%
13,431 $38,000
Q4 2023

Feb 14, 2024

SELL
$12.07 - $18.46 $107,833 - $164,921
-8,934 Reduced 37.87%
14,660 $215,000
Q3 2023

Feb 22, 2024

SELL
$18.08 - $23.45 $51,763 - $67,137
-2,863 Reduced 19.53%
11,797 $216,000
Q3 2023

Nov 14, 2023

BUY
$18.08 - $23.45 $426,579 - $553,279
23,594 New
23,594 $432,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.